Blueberries Medical, a Bogota, Colombia-based medical cannabis producer, has been cleared to produce and export CBD products from Colombian food and drug surveillance regulator Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA).
The five-product suite is Blueberries’ initial entry in the CBD market and includes creams, lip balm and shampoo.
The company plans to launch the product line in Colombia and Latin America in the second half of the year. The INVIMA approval is expected to help expedite the approval process in other Latin American countries.
Subscribe to our Newsletter
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers